Novel strategy for prevention of esophageal stricture after endoscopic surgery

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1150-1156

  Mizutani, Taro ^a   Tadauchi, Akimitsu ^a   Arinobe, Manabu ^b   Narita, Yuji ^a   Kato, Ryuji ^b   Niwa, Yasumasa ^d   Ohmiya, Naoki ^a   Itoh, Akihiro ^a   Hirooka, Yoshiki ^c   Honda, Hiroyuki ^b   Ueda, Minoru ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

5 FU; Collagen; Endoscopic submucosal dissection; Esophageal stricture; Liposome

Indexed keywords

ATELOCOLLAGEN; COLLAGEN; FLUOROURACIL; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOSCOPIC SURGERY; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FIBROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; SUSTAINED DRUG RELEASE; VOMITING;

ANIMALS; CELL PROLIFERATION; CICATRIX; DOGS; DRUG DELIVERY SYSTEMS; ESOPHAGEAL STENOSIS; ESOPHAGOSCOPY; FLUOROURACIL; HUMANS; LIPOSOMES;

EID: 79251551960     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. The Japan Esophageal Society: editor. Japanese Guidelines for Diagnosis and Treatment of Esophageal Cancer. 2007.
2. th Edition, Revised Version) 2008.
3. nd Edition).
4. Rajan E, Gostout C, Feitoza A, Herman L, Knipschield M, Burgart L, et al: Widespread endoscopic mucosal resection of the esophagus with strategies for stricture prevention: a preclinical study. Endoscopy 2005;37(11):1111-1115.
5. Miwako A, Hideaki A, Masahiro T: Bougie techniques for upper gastrointestinal stenosis. Stomach and Intestine (Tokyo) 2006; 41(4):617-622.
6. Berman B, Villa AM, Ramirez CC: Novel opportunities in the treatment and prevention of scarring. J Cutan Med Surg 2004; 8 Suppl 3:32-36. (Pubitemid 40685111)
7. Yagmurlu A, Aksu B, Bingol-Kologlu M, Renda N, Altinok G, Fitoz S, et al: A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling. Pediatr Surg Int 2004; 20(10):778-782.
8. Altintas E, Kacar S, Tunc B, Sezgin O, Parlak E, Altiparmak E, et al: Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation. J Gastroenterol Hepatol 2004; 19(12):1388-1391.
9. Arbell D, Udassin R, Koplewitz BZ, Ohana M, Genina O, Pines M, et al: Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis. Laryngoscope 2005; 115(9):1632-1635.
10. Cincik H, Gungor A, Cakmak A, Omeroglu A, Poyrazoglu E, Yildirim S, et al: The effects of mitomycin C and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma (experimental study). Am J Otolaryngol 2005; 26(1):45-50.
11. Crosasso P, Brusa P, Dosio F, Arpicco S, Pacchioni D, Schuber F, et al: Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs. J Pharm Sci 1997;86(7):832-9.
12. Daher P, Riachy E, Georges B, Georges D, Adib M: Topical application of mitomycin C in the treatment of esophageal and tracheobronchial stricture: a report of 2 cases. J Pediatr Surg 2007; 42(9):E9-11.
13. Ferguson B, Gray SD, Thibeault S: Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins. Laryngoscope 2005; 115(1):110-115. (Pubitemid 40096539)
14. Gillespie MB, Day TA, Sharma AK, Brodsky MB, Martin-Harris B: Role of mitomycin in upper digestive tract stricture. Head Neck 2007; 29(1):12-17.
15. Heran MK, Baird R, Blair GK, Skarsgard ED: Topical mitomycin-C for recalcitrant esophageal strictures: a novel endoscopic/fluoroscopic technique for safe endoluminal delivery. J Pediatr Surg 2008; 43(5):815-818.
16. Ingrams DR, Ashton P, Dhingra J, Shah R, Shapshay SM: Slow-release 5-fluorouracil and triamcinolone reduces subglottic stenosis in a rabbit model. Ann Otol Rhinol Laryngol 2000; 109(4):422-424.
17. Kaiser N, Kimpfler A, Massing U, Burger AM, Fiebig HH, Brandl M, et al: 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties. Int J Pharm 2003; 256(1-2):123-131.
18. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, Stefanaki K, Argyrakos T, Petridis A, et al: Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol 2005; 52(3 Pt 1):474-479.
19. Lee JP, Jalili RB, Tredget EE, Demare JR, Ghahary A: Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res 2005; 25(10):627-631.
20. Olutoye OO, Shulman RJ, Cotton RT: Mitomycin C in the management of pediatric caustic esophageal strictures: a case report. J Pediatr Surg 2006; 41(5):e1-3.
21. Ramage JI Jr., Rumalla A, Baron TH, Pochron NL, Zinsmeister AR, Murray JA, et al: A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol 2005; 100(11):2419-2425. (Pubitemid 43919671)
22. Rosseneu S, Afzal N, Yerushalmi B, Ibarguen-Secchia E, Lewindon P, et al: Topical application of mitomycin-C in oesophageal strictures. J Pediatr Gastroenterol Nutr 2007; 44(3):336-341.
23. Takeuchi M, Tredget EE, Scott PG, Kilani RT, Ghahary A: The antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds. J Interferon Cytokine Res 1999; 19(12):1413-1419.
24. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Simonoska M, et al: The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 2005; 291(1-2):79-86.
25. Immordino ML, Dosio F, Cattel L: Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006; 1(3):297-315. PMCID: 2426795.
26. Ito A, Honda H, Kobayashi T: Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother 2006; 55(3):320-328.
27. Sano A, Maeda M, Nagahara S, Ochiya T, Honma K, Itoh H, et al: Atelocollagen for protein and gene delivery. Adv Drug Deliv Rev 2003; 55(12):1651-1677.
28. Fry SW, Fleischer DE: Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 1997; 45(2):179-182.
29. Jeon SR, Eun SH, Shim CS, Ryu CB, Kim JO, Cho JY, et al: Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study. Endoscopy 2009; 41(5):449-456.
30. Nieponice A, McGrath K, Qureshi I, Beckman EJ, Luketich JD, Gilbert TW, et al: An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 2009; 69(2):289-296.
31. Ohki T, Yamato M, Murakami D, Takagi R, Yang J, Namiki H, et al: Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 2006; 55(12):1704-1710.
32. Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, et al: Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 2008; 53(2):330-333.
33. Sakurai T, Miyazaki S, Miyata G, Satomi S, Hori Y: Autologous buccal keratinocyte implantation for the prevention of stenosis after EMR of the esophagus. Gastrointest Endosc 2007; 66(1):167-173.
34. Siersema PD: Stenting for benign esophageal strictures. Endoscopy 2009; 41(4):363-373.
35. Toyohiko T, Norihisa N, Akira F, Michio Y, Masashi T, Kiyoshi M, et al: Development of biodegradable stent for gastrointestinal tract. Jpn J Intervent Radiol 2001; 61(11):S344-S345.
36. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, et al: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104(10):1188-1193.
37. Akinori M, Masatake M, Tsuyoshi K, Yosuke I, Hideto E, Jyunko F, et al: Key points of successful endoscopic treatments for postoperative esophageal strictures. Gastroenterological Endoscopy 2009; 51:1342-1348.
38. Atsuhiro M, Hiroki T, Masahiro I, Hiroshi Y, Yasunori M, Gou I, et al: Successful treatment of stricture type of ischemic proctitis by endoscopic balloon dilatation and transanal dilatation with Hegar's dilator: Report of a case. Gastroenterological Endoscopy 2004; 46(4):955-959.
39. Kazuyuki N, Masashi O, Naoki S, Tatsuya S, Tatsuji T, Kazuki U, et al: Endoscopic balloon dilatation of colonic stricture due to intestinal tuberculosis. Gastroenterological Endoscopy 2007; 49(7):1698-1703.
40. Takuya I, Yasumasa H, Kohsuke K, Masato S: Endoscopic balloon dilation of ileal stricture due to Crohn's disease: Report of the case. Gastroenterological Endoscopy 2003; 45(4):856-861.
41. Tamotsu S, Tasushi S, Tetsuji T, Seiichiro A, Masahiro A, Naoko A, et al: A case of pyloric stenosis after endoscopic submucosal dissection of early gastric cancer. Gastroenterological Endoscopy 2007; 49(7):1681-1687.